Magellan Healthcare Debuts Sleep Health Solution
09 Mars 2022 - 12:30PM
Business Wire
New solution connects members to the right test
at the right time to diagnose obstructive sleep apnea
Magellan Healthcare, the behavioral health and specialty
division of Magellan Health, Inc., today announced the release of
its new Sleep Health solution for payers, which is designed to
ensure members get the right test at the right time through the use
of sophisticated clinical intake algorithms and decision support
that reduces clinical variation and repeat testing.
More than a third of American adults report they are not getting
enough sleep on a regular basis.1 Obstructive sleep apnea (OSA),
the most common sleep-related breathing disorder, can contribute to
a variety of physical and mental health problems. OSA affects
approximately 25 million Americans, particularly individuals with
established risk factors and comorbid conditions such as
hypertension, heart disease, stroke, diabetes, anxiety and
depression. Of these, more than 80% are undiagnosed.2 Comorbidities
associated with undiagnosed sleep apnea account for $30 billion
annually in increased healthcare utilization and medication
costs.3
Currently, more than 70% of sleep studies are conducted in
hospitals or at a sleep center.4 When sleep apnea is suspected,
tests at high-cost facilities are completed at five times the rate
of more cost-effective home sleep tests (HSTs).5 Home sleep testing
can have several advantages over in-lab polysomnography, offering
eligible patients a convenient, more comfortable means of
evaluation. Magellan’s Sleep Health solution utilizes
expert-informed clinical guidelines and robust intake algorithms to
direct providers to the most appropriate test type. Lower cost home
sleep tests are recommended when clinically appropriate.
“March is National Sleep Awareness Month. Sleep is a critical
determinant of sound health and wellbeing, and for many, OSA is a
serious condition,” said Karen Jablonski, M.D., physician clinical
reviewer for Magellan Healthcare. “Magellan’s Sleep Health solution
for payers is an innovative way to tackle this critical issue by
helping to ensure the appropriate assessment of sleep apnea.”
Magellan will host the following virtual event focused on sleep
health:
Thursday, March 17, 2022, 2:00-3:00 p.m. ET: Join the
Magellan Healthcare webinar, “Obstructive Sleep Apnea: Impacts,
Diagnosis and Treatment,” with board-certified neurologist and
somnologist, Dr. Karen Jablonski, physician clinical reviewer,
Magellan Healthcare, and board-certified psychologist, Jamie Hanna,
M.D., medical director, Magellan Healthcare, as they address the
impacts of OSA on our physical and mental health and OSA diagnosis
and treatment. Click here for more information and free
registration.
For additional information about sleep health, visit
magellanhealthcare.com/health-plans/sleep-health/.
About Magellan Healthcare: Magellan Healthcare, Inc., the
healthcare business unit of Magellan Health, Inc., offers solutions
for complex conditions in the areas of behavioral health and
medical specialty treatment. Magellan Healthcare serves commercial
health plans, employers, state and local governments, and the
Federal government, including the Department of Defense. For more
information, visit MagellanHealthcare.com.
About Magellan Health: Magellan Health, Inc., is a leader
in managing the fastest growing, most complex areas of health,
including special populations, complete pharmacy benefits and other
specialty areas of healthcare. Magellan supports innovative ways of
accessing better health through technology, while remaining focused
on the critical personal relationships that are necessary to
achieve a healthy, vibrant life. Magellan's customers include
health plans and other managed care organizations, employers, labor
unions, various military and governmental agencies and third-party
administrators. For more information, visit MagellanHealth.com.
(MGLN-GEN)
______________________
1.
https://aasm.org/economic-burden-of-undiagnosed-sleep-apnea-in-u-s-is-nearly-150b-per-year/
2.
https://aasm.org/rising-prevalence-of-sleep-apnea-in
-u-s-threatens-public-health/
3.
https://j2vjt3dnbra3ps7ll1clb4q2-wpengine.netdna-ssl.com/wp-content/uploads/2017/10/sleep-apnea-economic-crisis.pdf
4.
Ibid
5.
http://www.sleepreviewmag.com/2014/02/15-osa-testing-done-hsts-growing/
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220309005071/en/
Media Contact: Lilly Ackley, ackleyl@magellanhealth.com,
(860) 507-1923
Magellan Health (NASDAQ:MGLN)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Magellan Health (NASDAQ:MGLN)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024